Publication
title
Federal Court Strengthens the Confidentiality of Information Held by Health Canada
DATE
October 1, 2004
EXPERTISE
In its recent decision Merck Frosst Canada & Co. v. Canada (Minister of Health), 2004 FC 959, the Federal Court restricted the disclosure of confidential information submitted by pharmaceutical companies to Health Canada as part of New Drug Submissions. The Court confirmed that the confidentiality obligations under the federal Access to Information Act apply not only to documents submitted by a third party in connection with a New Drug Submission but also to information derived from the documents.
Click here to read the article in PDF.
Contacts
Brian R. Daley
Montréal
514.847.4764
bdaley@ogilvyrenault.com
Profile
Judith M. Robinson
Montréal
514.847.4608
jrobinson@ogilvyrenault.com
Profile
Martha A. Healey
Ottawa
613.780.8638
mhealey@ogilvyrenault.com
Profile
Penny S. Bonner
Toronto
416.216.6629
pbonner@ogilvyrenault.com
Profile
